Witnessing the stock’s movement on the chart, on Wednesday, Evolent Health Inc (NYSE: EVH) had a quiet start as it plunged -2.44% to $22.40, before settling in for the price of $22.96 at the close. Taking a more long-term approach, EVH posted a 52-week range of $17.98-$35.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that the giant of the Healthcare sector posted annual sales growth of 27.32% over the last 5 years. Meanwhile, its Annual Earning per share during the time was -13.43%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 22.96%. This publicly-traded company’s shares outstanding now amounts to $113.89 million, simultaneously with a float of $110.62 million. The organization now has a market capitalization sitting at $2.60 billion.
Evolent Health Inc (EVH) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Health Information Services industry. Evolent Health Inc’s current insider ownership accounts for 4.87%, in contrast to 112.80% institutional ownership. According to the most recent insider trade that took place on Aug 22 ’24, this organization’s PRESIDENT sold 23,693 shares at the rate of 30.89, making the entire transaction reach 731,790 in total value, affecting insider ownership by 198,809. Preceding that transaction, on Aug 23 ’24, Company’s PRESIDENT sold 10,469 for 32.38, making the whole transaction’s value amount to 339,008. This particular insider is now the holder of 188,340 in total.
Evolent Health Inc (EVH) Earnings and Revenue Records
Evolent Health Inc’s EPS increase for this current 12-month fiscal period is 22.96% and is forecasted to reach 1.57 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 30.00% through the next 5 years, which can be compared against the -13.43% growth it accomplished over the previous five years trading on the market.
Evolent Health Inc (NYSE: EVH) Trading Performance Indicators
Let’s observe the current performance indicators for Evolent Health Inc (EVH). It’s Quick Ratio in the last reported quarter now stands at 1.08. The Stock has managed to achieve an average true range (ATR) of 1.13. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1.11. Similarly, its price to free cash flow for trailing twelve months is now 17.26.
In the same vein, EVH’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.94, a figure that is expected to reach 0.29 in the next quarter, and analysts are predicting that it will be 1.57 at the market close of one year from today.
